Archives
Lecanemab – a potential new treatment for Alzheimer’s disease
28 September 2022
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2022/09/GettyImages-650160957-150x150.jpg)
News that a potential treatment for early stage Alzheimer’s disease can slow cognitive decline is a significant development in dementia research. About the drug Lecanemab is an antibody that is designed to remove toxic beta-amyloid deposits; proteins that build up in the brains of people with Alzheimer’s disease. Following phase 3 clinical trials, pharmaceutical companies […]